XYMOGEN identifies allergen oversight by third-party manufacturer; issues recall of artriphen™
date:May 09, 2013
hat we had been dealing with a company that was clearly incompetent of segregating allergenic raw materials and communicating their presence in customers formulas. If it were not for XYMOGENs experienced and diligent team members that handle these processes, and our overall teams commitment to the utmost quality, this serious error may have remained undiscovered.

The U.S. Food and Drug Administrations (FDA) regulations on dietary manufacturing, packaging and distribution require manufactures to
5/6 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
07/08 20:21